scholarly article | Q13442814 |
P2093 | author name string | David H Sachs | |
Megan Sykes | |||
A Benedict Cosimi | |||
Tatsuo Kawai | |||
Immune Tolerance Network | |||
P2860 | cites work | HLA-mismatched renal transplantation without maintenance immunosuppression | Q33640791 |
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. | Q35083894 | ||
Induced immune tolerance for kidney transplantation | Q35906862 | ||
Risk of renal allograft loss from recurrent glomerulonephritis | Q74445034 | ||
CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates | Q80444346 | ||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1850-1852 | |
P577 | publication date | 2013-05-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | HLA-mismatched renal transplantation without maintenance immunosuppression | |
P478 | volume | 368 |
Q38694588 | A New Window into the Human Alloresponse |
Q91819943 | A Second Chance at Life |
Q52888768 | A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. |
Q35586614 | Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation |
Q41050325 | Anti-Interleukin-6 Promotes Allogeneic Bone Marrow Engraftment and Prolonged Graft Survival in an Irradiation-Free Murine Transplant Model |
Q49968823 | Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients |
Q38754342 | Cell therapeutic approaches to immunosuppression after clinical kidney transplantation |
Q91786100 | Cellular Therapies for the Treatment of Hematological Malignancies; Swine Are an Ideal Preclinical Model |
Q39215677 | Chimerism-based tolerance in organ transplantation: preclinical and clinical studies. |
Q47388499 | Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology. |
Q26745435 | Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance |
Q47100613 | Combining Adoptive Treg Transfer with Bone Marrow Transplantation for Transplantation Tolerance |
Q36279220 | Competitive Market Analysis of Transplant Centers and Discrepancy of Wait-Listing of Recipients for Kidney Transplantation |
Q92179702 | Composite tissue allotransplantation: opportunities and challenges |
Q89820624 | Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application |
Q21284774 | Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation |
Q50587076 | Dynamics of B Cell Recovery In Kidney/Bone Marrow Transplant Recipients. |
Q64982406 | Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. |
Q26770126 | Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation |
Q51095965 | Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival. |
Q89472835 | HLA in transplantation |
Q61798925 | Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation |
Q38309290 | Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance |
Q38935186 | Hematopoietic stem cells and solid organ transplantation |
Q90020912 | Human Intestinal Allografts Contain Functional Hematopoietic Stem and Progenitor Cells that Are Maintained by a Circulating Pool |
Q47636630 | Immune Tolerance, Xenografts, and Large-Animal Studies in Transplantation |
Q39314792 | Immune monitoring as prerequisite for transplantation tolerance trials |
Q48510142 | Immune monitoring of transplant patients in transient mixed chimerism tolerance trials |
Q38514510 | Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation |
Q36001563 | Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts. |
Q57296443 | Importance of Hematopoietic Mixed Chimerism for Induction of Renal Allograft Tolerance in Nonhuman Primates |
Q37109198 | Induced regulatory T cells in allograft tolerance via transient mixed chimerism |
Q39176256 | Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen |
Q34428845 | Induction of macrophage-like immunosuppressive cells from mouse ES cells that contribute to prolong allogeneic graft survival |
Q45074422 | Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation. |
Q37098988 | Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation |
Q36498594 | Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients |
Q38224758 | Lung transplantation: chronic allograft dysfunction and establishing immune tolerance |
Q88202733 | Lymphodepletive effects of rabbit anti-pig thymocyte globulin in neonatal swines |
Q36074384 | Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD. |
Q38725481 | Mesenchymal stromal cells in renal transplantation: opportunities and challenges. |
Q58789294 | Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation |
Q34352679 | Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection |
Q46055530 | Nephrology research--the past, present and future |
Q38614686 | Novel therapeutic and diagnostic management of heart transplant patients |
Q39267147 | Operational tolerance in kidney transplantation and associated biomarkers. |
Q50594543 | Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation Tolerance. |
Q49745662 | Orthotopic Hind Limb Transplantation in the Mouse |
Q97519150 | Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies |
Q41444299 | Recent Progress in Cell Therapy in Solid Organ Transplantation |
Q26800184 | Regulatory T Cells in Kidney Transplantation: New Directions? |
Q87729517 | Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier |
Q52570226 | Social, economic, and policy implications of organ preservation advances. |
Q64926518 | Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients. |
Q90955751 | Strategies to achieve immune tolerance in allogeneic solid organ transplantation |
Q38514485 | The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT. |
Q42039485 | Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients. |
Q37340107 | Transient mixed chimerism for allograft tolerance |
Q26752512 | Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies |
Q91554792 | Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation |
Q26751022 | Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms |
Q59400011 | Transplantation tolerance |
Q26829817 | Transplantation tolerance and its outcome during infections and inflammation |
Q92735518 | Transplantation tolerance in nonhuman primates and humans |
Q34082059 | Transplantation tolerance: from theory to clinic |
Q37677980 | Transplantology: Challenges for Today |
Q34536503 | Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates |
Q34761349 | What's new in clinical solid organ transplantation by 2013. |
Search more.